# Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

> **NCT05431803** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 129 (actual)

## Conditions studied

- Acromegaly

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05431803
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-30
- **Primary completion:** 2024-12-13
- **Final completion:** 2024-12-13
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05431803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05431803, "Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05431803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*